Back to Cognition
Cognition

TyrosineEvidence & Dosage

Dopamine/noradrenaline precursor, a stress buffer, cognitive performance under pressure.

Evidence at a glance

Total studies
161
With abstract
45
Meta / Systematic / RCT
2
Highly cited
50
Publication years
1967–2026

Tyrosine in the context of Cognition

This topic is part of our "Cognition" world. There you'll find methodology, evidence and the highest-impact levers — plus the order in which they sensibly build on each other.

Go to Cognition

Top studies on Tyrosine

Ranked by influential-citation count and publication year.

  1. Discovery of a Novel, Potent, and Src Family-selective Tyrosine Kinase Inhibitor

    Journal of Biological Chemistry1996223 influential citations

    Here, we have studied the activity of a novel protein-tyrosine kinase inhibitor that is selective for the Src family of tyrosine kinases. We have focused our study on the effects of this compound on T cell receptor-induced T cell…

  2. Efficacy and safety of a specific inhibitor of the BCR-ABL tyrosine kinase in chronic myeloid leukemia.

    New England Journal of Medicine2001n=83214 influential citations

    <h4>Background</h4>BCR-ABL is a constitutively activated tyrosine kinase that causes chronic myeloid leukemia (CML). Since tyrosine kinase activity is essential to the transforming function of BCR-ABL, an inhibitor of the kinase could be…

  3. mTOR inhibition induces upstream receptor tyrosine kinase signaling and activates Akt.

    Cancer research2006200 influential citations

    Stimulation of the insulin and insulin-like growth factor I (IGF-I) receptor activates the phosphoinositide-3-kinase/Akt/mTOR pathway causing pleiotropic cellular effects including an mTOR-dependent loss in insulin receptor substrate-1…

  4. BIBW2992, an irreversible EGFR/HER2 inhibitor highly effective in preclinical lung cancer models.

    Oncogene2008200 influential citations

    Genetic alterations in the kinase domain of the epidermal growth factor receptor (EGFR) in non-small cell lung cancer (NSCLC) patients are associated with sensitivity to treatment with small molecule tyrosine kinase inhibitors. Although…

  5. Activation of the AXL kinase causes resistance to EGFR-targeted therapy in lung cancer.

    Nature genetics2012n=5200 influential citations

    Human non-small cell lung cancers (NSCLCs) with activating mutations in EGFR frequently respond to treatment with EGFR-targeted tyrosine kinase inhibitors (TKIs), such as erlotinib, but responses are not durable, as tumors acquire…

  6. Therapeutic advances of targeting receptor tyrosine kinases in cancer.

    Signal transduction and targeted therapy2024200 influential citations

    Receptor tyrosine kinases (RTKs), a category of transmembrane receptors, have gained significant clinical attention in oncology due to their central role in cancer pathogenesis. Genetic alterations, including mutations, amplifications, and…

  7. Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders.

    The Lancet2005n=73199 influential citations

    <h4>Background</h4>Human myeloproliferative disorders form a range of clonal haematological malignant diseases, the main members of which are polycythaemia vera, essential thrombocythaemia, and idiopathic myelofibrosis. The molecular…

  8. AXL signaling in cancer: from molecular insights to targeted therapies.

    Signal transduction and targeted therapy2025194 influential citations

    AXL, a member of the TAM receptor family, has emerged as a potential target for advanced-stage human malignancies. It is frequently overexpressed in different cancers and plays a significant role in various tumor-promoting pathways,…

  9. Tyrosine Kinase Inhibitors in Cancer: Breakthrough and Challenges of Targeted Therapy.

    Cancers2020177 influential citations

    Receptor tyrosine kinases (RTKs) are key regulatory signaling proteins governing cancer cell growth and metastasis. During the last two decades, several molecules targeting RTKs were used in oncology as a first or second line therapy in…

  10. Activating and resistance mutations of EGFR in non-small-cell lung cancer: role in clinical response to EGFR tyrosine kinase inhibitors.

    Oncogene2009n=110175 influential citations

    The epidermal growth factor receptor tyrosine kinase inhibitors (EGFR TKIs), gefitinib and erlotinib, are reversible competitive inhibitors of the tyrosine kinase domain of EGFR that bind to its adenosine-5' triphosphate-binding site.…

More topics in Cognition

Bacopa Monnieri

Memory, Bacosides, Long-term Effect and Tolerance

Acetyl-L-Carnitine (ALCAR)

Mitochondria, neuroprotection, and energy metabolism.

Acetylcholine

Memory, attention, REM sleep, choline sources.

Active Recall

Retrieval over rereading — a scientifically superior way to learn.

Alpha-GPC

Choline source for acetylcholine and cognitive performance

Binaural Beats

Auditory frequency stimulation — mixed evidence.

Blood-Brain Barrier

Selective permeability, substance passage, inflammation-driven leakiness.

Brain Fog

Multifactorial: sleep, blood sugar, inflammation, thyroid, long COVID.

Caffeine

Adenosine-receptor antagonist, tolerance, timing, half-life, genetics.

Citicoline (CDP-Choline)

Phospholipid synthesis, ADHD, and neurological applications.

Creatine

More than just sport: memory, sleep deprivation, vegan deficits.

Deep Work

Focused, distraction-free work as a trainable skill.

Dopamine

Motivation, reward, movement, learning — the brain's core reward chemistry.

Dopamine Detox

A popular trend without strong scientific backing — what still holds up.

Exercise & Learning

BDNF, the hippocampus, cognitive reserve — exercise makes you sharper.

Flow State

Optimal state of consciousness during full immersion — conditions and triggers.

Ginkgo Biloba

Microcirculation, memory, and dementia interactions.

Glucose vs Ketones

The brain's fuel sources, ketogenic adaptation, cognitive effects.

Histamine

Wakefulness, allergy, histamine intolerance and brain fog.

L-Theanine

Alpha waves, relaxation without sedation, caffeine synergy.

Related topics from other worlds